Literature DB >> 23141857

Comorbidity significantly affects clinical outcome after cardiac resynchronization therapy regardless of ventricular remodeling.

Frederik H Verbrugge1, Matthias Dupont, Maximo Rivero-Ayerza, Philippe de Vusser, Hugo Van Herendael, Jan Vercammen, Linda Jacobs, David Verhaert, Pieter Vandervoort, W H Wilson Tang, Wilfried Mullens.   

Abstract

BACKGROUND: The influence of comorbid conditions on ventricular remodeling, functional status, and clinical outcome after cardiac resynchronization therapy (CRT) is insufficiently elucidated. METHODS AND
RESULTS: The influence of different comorbid conditions on left ventricular remodeling, improvement in New York Heart Association (NYHA) functional class, hospitalizations for heart failure, and all-cause mortality after CRT implantation was analyzed in 172 consecutive patients (mean age 71 ± 9 y), implanted from October 2008 to April 2011 in a single tertiary care hospital. During mean follow-up of 18 ± 9 months, 21 patients died and 57 were admitted for heart failure. Left ventricular remodeling and improvement in NYHA functional class were independent from comorbidity burden. However, diabetes mellitus (hazard ratio [HR] 3.45, 95% confidence interval [CI] 1.24-9.65) and chronic kidney disease (HR 3.11, 95% CI 1.10-8.81) were predictors of all-cause mortality, and the presence of chronic obstructive pulmonary disease (HR 1.89, 95% CI 1.02-3.53) was independently associated with heart failure admissions. Importantly, those 3 comorbid conditions had an additive negative impact on survival and heart failure admissions, even in patients with reverse left ventricular remodeling.
CONCLUSIONS: Reverse ventricular remodeling and improvement in functional status after CRT implantation are independent from comorbidity burden. However, comorbid conditions remain important predictors of all-cause mortality and heart failure admissions.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23141857     DOI: 10.1016/j.cardfail.2012.09.003

Source DB:  PubMed          Journal:  J Card Fail        ISSN: 1071-9164            Impact factor:   5.712


  9 in total

Review 1.  Optimizing CRT - Do We Need More Leads and Delivery Methods.

Authors:  Pieter Martens; Frederik Hendrik Verbrugge; Wilfried Mullens
Journal:  J Atr Fibrillation       Date:  2015-04-30

Review 2.  Optimizing Cardiac Resynchronization Therapy: an Update on New Insights and Advancements.

Authors:  Adam Grimaldi; Eiran Z Gorodeski; John Rickard
Journal:  Curr Heart Fail Rep       Date:  2018-06

3.  Combined management of atrial fibrillation and heart failure: case studies.

Authors:  Frederik H Verbrugge; Wilfried Mullens
Journal:  Heart Fail Rev       Date:  2014-05       Impact factor: 4.214

Review 4.  Cardiac resynchronization therapy in CKD: a systematic review.

Authors:  Neha Garg; George Thomas; Gregory Jackson; John Rickard; Joseph V Nally; W H Wilson Tang; Sankar D Navaneethan
Journal:  Clin J Am Soc Nephrol       Date:  2013-05-09       Impact factor: 8.237

Review 5.  Co-Morbidities and Cardiac Resynchronization Therapy: When Should They Modify Patient Selection?

Authors:  Martin H Ruwald
Journal:  J Atr Fibrillation       Date:  2015-06-30

Review 6.  Diabetes mellitus and risk of new-onset and recurrent heart failure: a systematic review and meta-analysis.

Authors:  Satoru Kodama; Kazuya Fujihara; Chika Horikawa; Takaaki Sato; Midori Iwanaga; Takaho Yamada; Kiminori Kato; Kenichi Watanabe; Hitoshi Shimano; Tohru Izumi; Hirohito Sone
Journal:  ESC Heart Fail       Date:  2020-07-29

7.  Aetiology of Heart Failure, Rather than Sex, Determines Reverse LV Remodelling Response to CRT.

Authors:  Fatema Said; Jozine M Ter Maaten; Pieter Martens; Kevin Vernooy; Mathias Meine; Cornelis P Allaart; Bastiaan Geelhoed; Marc A Vos; Maarten J Cramer; Isabelle C van Gelder; Wilfried Mullens; Michiel Rienstra; Alexander H Maass
Journal:  J Clin Med       Date:  2021-11-25       Impact factor: 4.241

8.  Contrast-induced acute kidney injury in patients undergoing cardiac resynchronization therapy-incidence and prognostic importance. Sub-analysis of data from randomized TRUST CRT trial.

Authors:  Jacek Kowalczyk; Radoslaw Lenarczyk; Oskar Kowalski; Tomasz Podolecki; Pawel Francuz; Patrycja Pruszkowska-Skrzep; Mariola Szulik; Michal Mazurek; Ewa Jedrzejczyk-Patej; Beata Sredniawa; Zbigniew Kalarus
Journal:  J Interv Card Electrophysiol       Date:  2014-03-14       Impact factor: 1.900

Review 9.  Impact of baseline renal function on all-cause mortality in patients who underwent cardiac resynchronization therapy: A systematic review and meta-analysis.

Authors:  G Bazoukis; K P Letsas; P Korantzopoulos; C Thomopoulos; K Vlachos; S Georgopoulos; N Karamichalakis; A Saplaouras; M Efremidis; A Sideris
Journal:  J Arrhythm       Date:  2017-05-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.